$country= Comparative statistics by cancer registry - SurvCan

Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site

(Chennai, India, 1990-1999 cases followed-up to 2001)

Click on cancer site (ICD-10 code) for comparison
Site ICD-10 No. of cases included Complete FUIncomplete FU: loss to FU% with Complete FU at 5 yearsMedian FU (in months)
Alive/deadAt end of FUNo.%% lost to FU: years from diagnosis
No.%<11-33-5>5
C00Lip865665.13034.97.02.30.025.690.727.3
C01-02Tongue98874775.624124.413.12.61.27.583.19.8
C03-06Oral cavity1662122173.544126.510.32.21.812.285.612.9
C09Tonsil25023092.0208.04.80.80.02.494.410.3
C10Other oropharynx15815195.674.40.60.60.03.298.711.0
C12-13Hypopharynx101789287.712512.39.00.70.32.390.08.7
C15Oesophagus2016181890.21989.86.70.90.41.892.06.9
C16Stomach2681239789.428410.67.30.90.91.590.96.1
C25Pancreas32831495.7144.33.10.30.30.696.34.3
C32Larynx72259882.812417.26.70.80.39.492.217.4
C33-34Lung1806161989.618710.48.00.70.31.491.15.8
C50Breast3067235176.771623.312.42.92.06.082.626.9
C53Cervix4438275262.0168638.011.03.72.520.882.827.5
C56Ovary80862577.418322.614.74.61.41.979.211.4
C67Urinary bladder44236783.07517.010.91.60.24.387.311.7
C81Hodgkin lymphoma29824582.25317.86.41.71.08.790.921.0
C82-85+C96Non-Hodgkin lymphoma86873284.313615.710.91.30.62.987.29.4
C91Lymphoid leukaemia43337285.96114.12.83.23.54.690.58.5
C92-94Myeloid leukaemia46540086.06514.08.61.30.43.789.74.5
C95Leukaemia unspecified857487.11112.910.50.00.02.489.41.5


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Chennai, India, 1990-1999 cases followed-up to 2001)
- Table2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Chennai, India, 1990-1999 cases followed-up to 2001)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Chennai, India, 1990-1999 cases followed-up to 2001)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Chennai, India, 1990-1999 cases followed-up to 2001)
- Table5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Chennai, India, 1990-1999)
- Table6: Comparison of 5-year absolute and relative survival of cases diagnosed between 1984-1989 and 1990-1999 (Chennai, India)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)